Global pharmaceutical company AstraZeneca (AZ) and the UK’s Medical Research Council (MRC) recently announced their groundbreaking collaboration deal to create a joint research facility that will be based at AZ’s new  biomedical research facility in the UK. Interestingly, our Editor-in-Chief David Janero recently commented on the potential for productive university, industry, and government relationships in preclinical drug discovery and development.

The editorial office are happy to highlight LH Tseng‘s review on the “Advances in the methods for discovering novel painful bladder syndrome therapies” from our April issue of Expert Opinion on Drug Discovery. Please see inside for more details.

Following the outbreak of Ebola in Guinea, Expert Opinion on Drug Discovery looks back at a recent publication reviewing some of the efforts made to tackle the currently untreatable virus.

We are happy to present SK Sandiford’s informative article on the “Advances in the arsenal of tools available enabling the discovery of novel lantibiotics with therapeutic potential” as our Editorial Highlight from the March issue of Expert Opinion on Drug Discovery.

This month, it was announced by the World Health Organisation (WHO) that global deaths caused by measles have declined by as much as 77%. Yet, even with this large decline, the WHO is still keen to stress the global threat it poses. This month in Expert Opinion in Drug Discovery, Richard K Plemper et al. look into how synergizing vaccinations of measles could further aid measles eradication.

The editorial team is happy to highlight “The future of crystallography in drug discovery” by H Zheng, J Hou, MD Zimmerman et al. as our editorial highlight for the February issue of Expert Opinion on Drug Discovery.

Protein tyrosine kinase inbitors are considered to be one of the most important classes of drug therapy in the fight against cancer. For this reason, the editorial team would like to highlight this interesting article on “Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer” from our January issue of Expert Opinion on Drug Discovery.

Want to learn more about some of the in vitro methods being used to discover and develop drugs? Both Expert Opinion on Drug Discovery and Expert Opinion on Drug Metabolism & Toxicology have been examining just that – click above to find out more.

The Expert Opinion & Expert Reviews journals are now on facebook! Click here to visit our page and ‘LIKE’ us to keep updated of the newest articles and hottest news!

Five articles from the Expert Opinion Series are within the top 100 most accessed articles from the Informa healthcare journal portfolio in November 2013

3D in vitro tissue models and their potential for drug screening by Lauren Kimlin and colleagues is our Editor’s pick from the December issue of Expert Opinion on Drug Discovery from Editor-in-Chief Professor David Janero.

As it is currently Epilepsy Awareness Month in the United States, we would like to highlight our article on “Novel approaches to anticonvulsant drug discovery” in the November issue of Expert Opinion on Drug Discovery.

Our Editor in Chief has happily chosen “Predictive approaches to increase absorption of compounds during lead optimisation”, written by K Valko et al., as his pick for the latest issue of Expert Opinion on Drug Discovery.

I am delighted to inform you that our Editor-in-Chief, David Janero has selected Hoertel et al.’s review article on “Novel Routes to Bipolar Drug Discovery” as his Editor’s Pick for the August issue of Expert Opinion on Drug Discovery.

Inflammatory Bowel Disease is typified by the chronic inflammation of the gastrointestinal tract, and is in urgent need of novel drug discovery and development. Expert Opinion on Drug Discovery reviews this very interesting and topical area

The August 2013 issue of Expert Opinion on Drug Discovery has now been published and we are delighted to highlight this fascinating recent article on “Novel Routes to Bipolar Disorder Drug Discovery” published by Hoertel, de Maricourt and Gorwood. This article reviews the targets of current mood-stabilizing drugs and highlights the potential new avenues for future drug discovery and development.

Expert Opinion on Drug Discovery is happy to highlight the publication of our latest Drug Discovery Case History on Prasugrel published by J Shan and H Sun.

Our editor in chief has chosen the article entitled “Recent progress in robot-based systems for crystallography and their contribution to drug discovery” by Ferrer JL et al. as the Editor’s pick for the July edition of the 2013 volume of Expert Opinion on Drug Discovery.

Our editor in chief has chosen the article entitled “X-ray structural information of GPCRs in drug design: what are the limitations and where do we go?” by Topiol as the Editor’s pick for the June edition of the 2013 volume of Expert Opinion on Drug Discovery.

Expert Opinion on Investigational Drugs would like to present a special issue dedicated to protein kinase inhibitors. These small molecules have potential to be active therapies in a wide variety of indications, from oncology through to neurology and beyond. Along with Guest Editor Tomi Sawyer, we explore some of the interesting drugs which fall into this class in this special issue of EOID.

Expert Opinion on Drug Discovery is delighted to welcome David Janero as the new Editor-in-Chief of our journal.

We are delighted to be able to annonuce that Expert Opinion on Drug Discovery has been accepted onto MEDLINE.

In the interests of transparency, the editors would like to take the opportunity to update our readers on our ethical policies, and assure you that we take any breach of said policies very serieously, and will will investigate all such issues as fully as possible.

We are delighted that Dr Dino Montanari, of Aptuit Verona, has provided a podcast introduction to his manuscript, ‘Application of drug efficiency index in drug discovery: a strategy towards low therapeutic dose’ that was published in the September issue of Expert Opinion of Drug Discovery.